Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 24 (9), 1092-1100

Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery


Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery

Fleur Weeber et al. Cell Chem Biol.


Tumor organoids are 3D cultures of cancer cells that can be derived on an individual patient basis with a high success rate. This creates opportunities to build large biobanks with relevant patient material that can be used to perform drug screens and facilitate drug development. The high take rate will also allow side-by-side comparison to evaluate the translational potential of this model system to the patient. These tumors-in-a-dish can be established for a variety of tumor types including colorectal, pancreas, stomach, prostate, and breast cancers. In this review, we highlight what is currently known about tumor organoid culture, the advantages and challenges of the model system, compare it with other pre-clinical cancer models, and evaluate its value for drug development.

Keywords: PDX; biobank; cell line; drug development; drug screen; patient-derived tumor organoids; patient-derived xenograft; three-dimensional culture; tumor organoids.

Similar articles

See all similar articles

Cited by 62 articles

See all "Cited by" articles

MeSH terms


LinkOut - more resources